<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2003-7-4-66-70</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-977</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ. ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES. EXPERIMENTAL INVESTIGATION</subject></subj-group></article-categories><title-group><article-title>ВЛИЯНИЕ СОДЕРЖАНИЯ БЕЛКА В ДИЕТЕ НА ПРОГРЕССИРОВАНИЕ ЭКСПЕРИМЕНТАЛЬНОЙ ХРОНИЧЕСКОЙ ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ</article-title><trans-title-group xml:lang="en"><trans-title>EFFECTS OF DIETARY PROTEIN ON THE DEVELOPMENT OF EXPERIMENTAL CHRONIC RENAL FAILURE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Береснева</surname><given-names>О. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Beresneva</surname><given-names>O. N.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Парастаева</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Parastaeva</surname><given-names>M. M.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кучер</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kucher</surname><given-names>A. G.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванова</surname><given-names>Г. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanova</surname><given-names>G. T.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каюков</surname><given-names>И. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kayukov</surname><given-names>I. G.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Митрофанова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mitrofanova</surname><given-names>O. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Научно-исследовательский институт нефрологии, Санкт-Петербургский государственный медицинский университет им.акад. И.П. Павлова, Институт физиологии им. И.П. Павлова РАН</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2003</year></pub-date><pub-date pub-type="epub"><day>10</day><month>04</month><year>2003</year></pub-date><volume>7</volume><issue>4</issue><fpage>66</fpage><lpage>70</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Береснева О.Н., Парастаева М.М., Кучер А.Г., Иванова Г.Т., Каюков И.Г., Митрофанова О.В., 2003</copyright-statement><copyright-year>2003</copyright-year><copyright-holder xml:lang="ru">Береснева О.Н., Парастаева М.М., Кучер А.Г., Иванова Г.Т., Каюков И.Г., Митрофанова О.В.</copyright-holder><copyright-holder xml:lang="en">Beresneva O.N., Parastaeva M.M., Kucher A.G., Ivanova G.T., Kayukov I.G., Mitrofanova O.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/977">https://journal.nephrolog.ru/jour/article/view/977</self-uri><abstract/><trans-abstract xml:lang="en"><p>THEAIM of the work was to investigate effects of ketosteril and SUPRO 760 found in nutritional ration on the development of experimental chronic renal failure (CRF) in Wistar rats. Amodel of CRF was made by means of a standard two-stage operation (5/ 6 nephrectomy). MATERIALS AND METHODS. Under investigation there were 5 groups of rats: 1. rats with 5/6 nephrectomy (NE) given a standard diet; 2. rats which in two weeks after NEwere given the diet having ketosteril (10% ketosteril + 90% carbohydrate) for the following 6 weeks; 3. rats given the diet containing SUPRO 760 (10% soy protein + 90% carbohydrate)after NE; 4. sham operated rats given the standard diet (control group); 5. sham operated rats given SUPRO 760 (10% soy protein + 90% carbohydrate). RESULTS. Within 8 weeks after NEthe uremic rats were compared with the sham operated controls. The uremic rats (group 1)had elevated urea, cholesterol, phosphorus and reduced total calcium in blood serum as compared to the control. The content of urea, cholesterol, phosphorus in blood serum of rats given the diet with SUPRO 760 or ketosteril was Iowerthan that in group 1, though was higher than the indices of the control groups. Calcium level was not reduced. Arterial pressure was considerably higher in group 1 than in groups 2 and 3. Hypertrophy of the left heart ventricle was less in the rats given SUPRO 760 after NE (group 3) than in groups 1 and 2. CONCLUSION. The investigations performed have revealed positive effects of SUPRO 760 on slowing down the development of experimental CRF and confirmed the possibility to use soy proteins in nutritional ration of neurological patients.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>экспериментальная хроническая почечная недостаточность</kwd><kwd>низкобелковая диета</kwd><kwd>SUPRO 760</kwd></kwd-group><kwd-group xml:lang="en"><kwd>experimental chronic renal failure</kwd><kwd>low protein diet</kwd><kwd>SUPRO 760</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ермоленко BM. Малобелковая диета при хронической почечной недостаточности. В: Рябов СИ, ред. Лечение хронической почечной недостаточности. Фолиант, СПб. 1997;135-146</mixed-citation><mixed-citation xml:lang="en">Ермоленко BM. Малобелковая диета при хронической почечной недостаточности. В: Рябов СИ, ред. Лечение хронической почечной недостаточности. Фолиант, СПб. 1997;135-146</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Кучер АГ Проблемы лечебного питания у больных с хронической почечной недостаточностью. Нефрология 1997; (1):79-84</mixed-citation><mixed-citation xml:lang="en">Кучер АГ Проблемы лечебного питания у больных с хронической почечной недостаточностью. Нефрология 1997; (1):79-84</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Levey AS, Adler S, Caggiula AW et al. Effects of dietary protein restriction on the progression of advanced renal disease in the modification of diet in renal disease study. Am J Kidney Dis 1996; 27 (5):652-663</mixed-citation><mixed-citation xml:lang="en">Levey AS, Adler S, Caggiula AW et al. Effects of dietary protein restriction on the progression of advanced renal disease in the modification of diet in renal disease study. Am J Kidney Dis 1996; 27 (5):652-663</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Бреннер БМ. Механизмы пргрессирования болезней почек. Нефрология 1999; (3):23-27</mixed-citation><mixed-citation xml:lang="en">Бреннер БМ. Механизмы пргрессирования болезней почек. Нефрология 1999; (3):23-27</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Messina М, Gardner С, Barnes S. Gaining insight into the health effects of soy but a long way still to go: commentary on the fourth international symposium on the role of soy in preventing and treating chronic disease. J Nutr 2002; 132(2):547S-551S</mixed-citation><mixed-citation xml:lang="en">Messina М, Gardner С, Barnes S. Gaining insight into the health effects of soy but a long way still to go: commentary on the fourth international symposium on the role of soy in preventing and treating chronic disease. J Nutr 2002; 132(2):547S-551S</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Polzin DJ, Osborne CA, Ross S, Jacob F. Dietary management of feline chronic renal failure: where are we now? In what direction are we headed? J Feline Med Surg 2000; 2(2): 75-82</mixed-citation><mixed-citation xml:lang="en">Polzin DJ, Osborne CA, Ross S, Jacob F. Dietary management of feline chronic renal failure: where are we now? In what direction are we headed? J Feline Med Surg 2000; 2(2): 75-82</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Schafer L, Meier K, Hafner C et al. Protein restriction influences glomerular matrix turnover and tubular hypertrophy by modulation of renal proteinase activities. Mineral Electrolyte Metab 1996; 22 (1-3): 162-167</mixed-citation><mixed-citation xml:lang="en">Schafer L, Meier K, Hafner C et al. Protein restriction influences glomerular matrix turnover and tubular hypertrophy by modulation of renal proteinase activities. Mineral Electrolyte Metab 1996; 22 (1-3): 162-167</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Soroka N, Silverberg DS, Greemland M et al. Comparison of a vegetable-based (soya) and an animal-based low -protein diet in predialysis chronic renal failure patients. Nephron 1998; 72 (2): 173-180</mixed-citation><mixed-citation xml:lang="en">Soroka N, Silverberg DS, Greemland M et al. Comparison of a vegetable-based (soya) and an animal-based low -protein diet in predialysis chronic renal failure patients. Nephron 1998; 72 (2): 173-180</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Лифшиц НЛ, Николаев АЮ. Применение диеты с различным содержанием белка в сочетании с кетоаналогами незаменимых аминокислот при лечении хронической почечной недостаточности. Современное состояние проблемы. Tep арх 1999; (1):74-77</mixed-citation><mixed-citation xml:lang="en">Лифшиц НЛ, Николаев АЮ. Применение диеты с различным содержанием белка в сочетании с кетоаналогами незаменимых аминокислот при лечении хронической почечной недостаточности. Современное состояние проблемы. Tep арх 1999; (1):74-77</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Tzekov VDб Tilkian ЕЕ, Pandeva SM et al. Low protein diet and ketosteril in predialysis patients with renal failure. Folia Med(PIovdiv) 2000; 42(2): 34-37</mixed-citation><mixed-citation xml:lang="en">Tzekov VDб Tilkian ЕЕ, Pandeva SM et al. Low protein diet and ketosteril in predialysis patients with renal failure. Folia Med(PIovdiv) 2000; 42(2): 34-37</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zakar G. The effect of a keto acid supplement on the course of chronic renal failure and nutritional parameters in predialysis patients and patients on regular hemodialysis therapy: the Hungarian Ketosteril Cohort Study. Wien Klin Wochenschr 2001; 113(17-18): 688-694</mixed-citation><mixed-citation xml:lang="en">Zakar G. The effect of a keto acid supplement on the course of chronic renal failure and nutritional parameters in predialysis patients and patients on regular hemodialysis therapy: the Hungarian Ketosteril Cohort Study. Wien Klin Wochenschr 2001; 113(17-18): 688-694</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Locatelli F. Is the type of protein in the diet more important that its quantity for slowing progression of chronic renal insufficiency? Nephrol Dial Transplant 1997; 12(3): 391-393</mixed-citation><mixed-citation xml:lang="en">Locatelli F. Is the type of protein in the diet more important that its quantity for slowing progression of chronic renal insufficiency? Nephrol Dial Transplant 1997; 12(3): 391-393</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Fournier D, Erdman JW, Gordon GB. Soy, its components and cancer prevention: a review of the in vitro, animal and human data. Cancer Epidemiology, Biomarkers and Prevention (Baltimore) 1998; 7(11): 1055-1065</mixed-citation><mixed-citation xml:lang="en">Fournier D, Erdman JW, Gordon GB. Soy, its components and cancer prevention: a review of the in vitro, animal and human data. Cancer Epidemiology, Biomarkers and Prevention (Baltimore) 1998; 7(11): 1055-1065</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kaneko Kб Masaki U, Aikio M et al. Urinary calcium and calcium balance in young women affected by high protein diet of soy protein isolate and adding sulfurcontaining amino acids and for potassium. J Nutr Sci Vitaminol 1990; 36(2); 105-116</mixed-citation><mixed-citation xml:lang="en">Kaneko Kб Masaki U, Aikio M et al. Urinary calcium and calcium balance in young women affected by high protein diet of soy protein isolate and adding sulfurcontaining amino acids and for potassium. J Nutr Sci Vitaminol 1990; 36(2); 105-116</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Barnes S. Evolution of the health benefits of soy isoflavones. Proc Soc Exp Biol Med (Cambridge) 1998; 217(3): 386-392</mixed-citation><mixed-citation xml:lang="en">Barnes S. Evolution of the health benefits of soy isoflavones. Proc Soc Exp Biol Med (Cambridge) 1998; 217(3): 386-392</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Gentil M Gб Manna G, D’Amico G. Soy consumption and renal function in patients with nephrotic syndrom: clinical effects and potential mechanism. Am J Clin Nutr 1998; 68 [Suppl 6]: 151-165</mixed-citation><mixed-citation xml:lang="en">Gentil M Gб Manna G, D’Amico G. Soy consumption and renal function in patients with nephrotic syndrom: clinical effects and potential mechanism. Am J Clin Nutr 1998; 68 [Suppl 6]: 151-165</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Барабанова BB, Береснева ОН. Является ли паратиреоидный гормон основным повреждающим фактором сосудов печени при экспериментальной почечной недостаточности? Нефрология 1998; 2(1): 99-104.</mixed-citation><mixed-citation xml:lang="en">Барабанова BB, Береснева ОН. Является ли паратиреоидный гормон основным повреждающим фактором сосудов печени при экспериментальной почечной недостаточности? Нефрология 1998; 2(1): 99-104.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Canneila G, Messa P. Pathogenesis and treatment of secondary hyperparathyroidism in chronic renal disease. IntJ Artif Organs 1999; 22(1): 1-7</mixed-citation><mixed-citation xml:lang="en">Canneila G, Messa P. Pathogenesis and treatment of secondary hyperparathyroidism in chronic renal disease. IntJ Artif Organs 1999; 22(1): 1-7</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
